Dr. Kave Moloudi | Oxidative stress | Research Excellence Award
Dr. Kave Moloudi | Oxidative stress | Postdoctoral Researcher at University in Caen | France
Oxidative stress is a central theme in the scholarly contributions of Dr. Kave Moloudi, a distinguished Postdoctoral Researcher at the Laboratoire Aliments, Bioprocédés, Toxicologie Environnements, University of Caen, Normandy, France. Dr. Kave Moloudi earned his Ph.D. in Biomedical Sciences from the University of Johannesburg, South Africa, with his dissertation titled “Evaluation of Nano-Phytoformulations of Berberine and Pheophorbide-a Mediated Photodynamic Therapy on a Human 3D Lung Cancer Cell Model,” reflecting a rigorous scientific pursuit in combating cancer, particularly through the management of oxidative stress, photodynamic therapy, and nano-phytoformulations. Previously, he completed an MSc in Radiobiology and Radiation Protection at Iran University of Medical Sciences (IUMS), focusing on radio-chemotherapy for 3D glioblastoma models, and earlier earned a BSc and Associate Degrees in Radiology Technology from Tehran University of Medical Sciences (TUMS) and Kurdistan University of Medical Sciences (KUMS). The career of Dr. Kave Moloudi includes impactful professional involvement as Lecturer at the University of Johannesburg and Lecturer/Research Assistant at Kermanshah University of Medical Sciences, where he contributed both to clinical and academic mentoring. His earlier clinical experience from includes extensive radiology practice at Imam Khomeini Hospital and Negarh Radiology Center, mastering MRI, CT scan, CBCT, and emergency care systems, enabling him to correlate imaging principles with cellular and molecular understanding of oxidative stress, nanotheranostics, photodynamic therapy, and radiobiology. His research interests align with nanotechnology, photodynamic therapy, medical imaging, and cancer biology, specifically examining oxidative stress modulation and treatment resistance in malignancies. Dr. Kave Moloudi demonstrates impressive technical skills—ranging from sophisticated molecular biology assays (MTT, flow cytometry, Western blotting, PCR, confocal microscopy, LDH assays, mitochondrial membrane potential assays) to nanomaterial synthesis and medical image processing using ImageJ and SYNGO platforms, proving his multifaceted expertise. He has been recognized with several prestigious honors including the PhD Top Achiever Awards at the Laser Research Centre, Global Excellence and Stature (GES) bursary, and high national rankings in Iranian MSc and BSc admission examinations. Dr. Kave Moloudi has further served as Guest Associate Editor for influential journals such as Frontiers in Immunology, Frontiers in Oncology, and Pharmacology of Anti-Cancer Drugs, showcasing his scholarly leadership. His ongoing research aims to advance nanotheranostics, photodynamic methods, and modulation of oxidative stress mechanisms toward precise cancer therapy strategies. In conclusion, Dr. Kave Moloudi has built a remarkable academic and clinical record that integrates biomedical sciences, nanotechnology, photodynamic therapy, and oxidative stress modulation, marking him as a rising expert committed to cancer treatment innovations with translational biomedical applications.
Featured Publications
Moloudi, K. (2023). Photodynamic therapy induced cell cycle arrest and cancer cell synchronization. Frontiers in Oncology, 13, 1225694. 38 citations.
Keshavarz, M., Moloudi, K., Paydar, R., Abed, Z., Beik, J., & Ghaznavi, H. (2018). Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy. Journal of Biomaterials Applications, 33(2), 161–169. 83 citations.
Ashrafizadeh, M., Taeb, S., Haghi-Aminjan, H., Afrashi, S., Moloudi, K., & others. (2021). Resveratrol as an enhancer of apoptosis in cancer: A mechanistic review. Anti-Cancer Agents in Medicinal Chemistry, 21(17), 2327–2336. 67 citations.
Moslehi, M., Moazamiyanfar, R., Dakkali, M. S., Rezaei, S., Rastegar-Pouyani, N., Moloudi, K., & others. (2022). Modulation of the immune system by melatonin; implications for cancer therapy. International Immunopharmacology, 108, 108890. 49 citations.
Abdollahzadeh, R., Fard, M. S., Rahmani, F., Moloudi, K., & Azarnezhad, A. (2016). Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study. Journal of the Neurological Sciences, 367, 148–151. 48 citations.
Lalani, A. R., Fakhari, F., Radgoudarzi, S., Rastegar-Pouyani, N., Moloudi, K., & others. (2023). Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression. Clinical and Experimental Pharmacology and Physiology, 50(5), 353–368. 36 citations.
Moazamiyanfar, R., Rezaei, S., AliAshrafzadeh, H., Rastegar-Pouyani, N., Moloudi, K., & others. (2023). Nobiletin in cancer therapy; mechanisms and therapy perspectives. Current Pharmaceutical Design, 29(22), 1713–1728. 35 citations.
Amini, P., Moazamiyanfar, R., Dakkali, M. S., Moloudi, K., & others. (2022). Resveratrol in cancer therapy: From stimulation of genomic stability to adjuvant cancer therapy: A comprehensive review. Current Topics in Medicinal Chemistry. 46 citations.
Narmani, A., Jahedi, R., Bakhshian-Dehkordi, E., Ganji, S., Nemati, M., Moloudi, K., & others. (2023). Biomedical applications of PLGA nanoparticles in nanomedicine: Advances in drug delivery systems and cancer therapy. Expert Opinion on Drug Delivery, 20(7), 937–954. 83 citations.